[HTML][HTML] Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk
JM Mostaza, C Escobar - Journal of Clinical Medicine, 2024 - mdpi.com
Vascular diseases are the leading cause of death in Spain. Hypercholesterolemia is not only
a cardiovascular risk factor, but also underlies the etiopathogenesis of atherosclerosis …
a cardiovascular risk factor, but also underlies the etiopathogenesis of atherosclerosis …
Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk
JM Mostaza, C Escobar - Journal of clinical medicine, 2024 - pubmed.ncbi.nlm.nih.gov
Vascular diseases are the leading cause of death in Spain. Hypercholesterolemia is not only
a cardiovascular risk factor, but also underlies the etiopathogenesis of atherosclerosis …
a cardiovascular risk factor, but also underlies the etiopathogenesis of atherosclerosis …
Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk.
JM Mostaza, C Escobar - Journal of Clinical Medicine, 2024 - search.ebscohost.com
Vascular diseases are the leading cause of death in Spain. Hypercholesterolemia is not only
a cardiovascular risk factor, but also underlies the etiopathogenesis of atherosclerosis …
a cardiovascular risk factor, but also underlies the etiopathogenesis of atherosclerosis …
[HTML][HTML] Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk
JM Mostaza, C Escobar - Journal of Clinical Medicine, 2024 - ncbi.nlm.nih.gov
Vascular diseases are the leading cause of death in Spain. Hypercholesterolemia is not only
a cardiovascular risk factor, but also underlies the etiopathogenesis of atherosclerosis …
a cardiovascular risk factor, but also underlies the etiopathogenesis of atherosclerosis …
Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk.
JM Mostaza, C Escobar - Journal of Clinical Medicine, 2024 - europepmc.org
Vascular diseases are the leading cause of death in Spain. Hypercholesterolemia is not only
a cardiovascular risk factor, but also underlies the etiopathogenesis of atherosclerosis …
a cardiovascular risk factor, but also underlies the etiopathogenesis of atherosclerosis …
Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk.
JM Mostaza, C Escobar - Journal of Clinical Medicine, 2024 - europepmc.org
Vascular diseases are the leading cause of death in Spain. Hypercholesterolemia is not only
a cardiovascular risk factor, but also underlies the etiopathogenesis of atherosclerosis …
a cardiovascular risk factor, but also underlies the etiopathogenesis of atherosclerosis …